In contrast, in the present study, we observed a significant decrease in the level of Bcl-2 accompanied by increased levels of Bax, caspase-3, and caspase-9, indicating that pristimerin is able to trigger intrinsic apoptosis thereby inducing esophageal cancer cell death. Here, BCL2 is linked to esophageal cancer.